Author: admin

The below Parliamentary question was asked by Luciana Berger on 2014-06-17.

To ask the Secretary of State for Health, what (a) amount and (b) proportion of Public Health England’s marketing budget has been allocated to each of the six Big Ambitions referred to in its 2014-15 business plan.

Jane Ellison

The core Public Health England (PHE) marketing budget for 2014-15 is £53 million. The allocation to each of the six big ambition areas is as follows:

Ambition	Campaign	Budget for 2014-15	Percentage of total budget
Tobacco	Smokefree	£11,689,200	21.72
Obesity	Change 4 Life	£9,360,000	17.39
Dementia	Vascular dementia programme and dementia friends	£5,460,000	10.14
Best start in life	Start4Life and Information Service for Parents	£3,450,000	6.41
Alcohol	Alcohol	£2,000,000	3.72
Tuberculosis (TB)		£0	0.0
		£31,959,200	59.38

The current assessment of the evidence shows that a national marketing campaign on TB would not be a cost effective investment so there is no marketing budget allocation to this ambition area.

In addition to the individual campaign costs stated above an additional £3.3 million is also spent on call centres and £2.6 million is also spent on infrastructure costs such as evaluation. The final budget will be subject to clearance by the Cabinet Office’s Efficiency and Reform Group.

PHE’s 2014-15 Marketing strategy is due for publication in early July and will provide more detailed information on the full marketing programme.

The below Parliamentary question was asked by Luciana Berger on 2014-06-17.

To ask the Secretary of State for Health, what (a) amount and (b) proportion of Public Health England’s total budget has been allocated to (i) tobacco, (ii) obesity, (iii) alcohol, (iv) TB, (v) dementia and (vi) the Best Start in Life strategy for 2014-15.

Jane Ellison

Public Health England’s (PHE) financial reporting is currently based upon the Directorates and teams around which their work is focused. The six areas of focus identified in the Parliamentary Questions are currently supported by individuals and teams across PHE’s various directorates (Operations, Health Protection, Health and Wellbeing, Knowledge etc.), so the total cost of each of the above areas cannot currently be accurately provided.

During the course of 2014-15, one of the priorities identified by PHE’s Finance team is to enhance and tailor their inherited financial reporting arrangements so that it can report on their activities and priorities as well as its Directorates and teams. PHE will be able to provide this information in the future, but it is unfortunately not available now. Once PHE has developed new financial reporting arrangements they will ensure that this is published transparently.

The below Parliamentary question was asked by Luciana Berger on 2014-06-17.

To ask the Secretary of State for Health, what steps he is taking to encourage the uptake of chlamydia screening.

Jane Ellison

The Public Health Outcomes Framework includes a chlamydia diagnosis rate indicator – one of three sexual health indicators in the framework. Public Health England (PHE) encourages local authorities to work towards achieving a rate of 2,300 diagnoses per 100,000 young adult populations.

The National Chlamydia Screening Programme (NCSP) supports this aim through:

– Publishing chlamydia screening standards, to form the basis of local screening planning, delivery and quality assurance;

– Producing guidance to support local commissioners and providers in the delivery of chlamydia screening, including forthcoming publication ‘Achieving the diagnostic rate indicator’;

– Reviewing and summarising the latest evidence to inform evidence-based and cost-effective approaches to chlamydia screening;

– Collecting and publishing chlamydia data, at a national and local level, to monitor screening and detection activity;

– Providing information to young adults on chlamydia, chlamydia screening and wider sexual health matters (e.g. condom use, contraception), including via a website;

– Supporting the implementation of specific programmes to increase chlamydia screening rates, such as the ‘3Cs & HIV Programme’. This is currently being piloted across England to encourage the routine offer of chlamydia screening, alongside information on contraception and condoms, to young adults during primary care appointments;

– A team of PHE sexual health facilitators, who are linked closely into local commissioner and provider sexual health networks, with a focus on promoting chlamydia screening; and

– Evaluating the impact of the NCSP, including development of different approaches to estimate and monitor prevalence, such as mathematical modelling.

The below Parliamentary question was asked by Luciana Berger on 2014-06-17.

To ask the Secretary of State for Health, pursuant to the Answer of 12 June 2014, Official Report, column 281W, on food banks, whether (a) he and (b) other Ministers in his Department plan to visit a food bank in order to assess the contribution of food banks to public health and nutrition.

Dr Daniel Poulter

There are nocurrent plans for ministers in the Department to visit a food bank, but this does not preclude planned visits in their wider capacities or as constituency MPs. We would consider undertaking an official visit, if an invitation was received.

The below Parliamentary question was asked by Luciana Berger on 2014-06-17.

To ask the Secretary of State for Health, what (a) number and (b) proportion of adult cystic fibrosis centres in England have (i) reached and (ii) exceeded the maximum capacity of 250 patients recommended by the Cystic Fibrosis Trust in each of the last four years.

Norman Lamb

Information concerning the number of adult cystic fibrosis (CF) patients cared for by CF centres in England in each of the last four years is not available. This data has only been collected since the introduction of the tariff for CF services in 2011.

In the attached table we have provided the number and proportion of CF centres treating 250 patients or more in each of the last three years.

It should be noted that theStandards of Care, updated by CF Trust in 2011 does not state that 250 patients is the maximum number a CF centre should treat, but rather that when a centre reaches 250 patients, and anticipates that numbers will continue to rise, the development of alternative specialist centres should be considered.